Explore dQ&A’s First Look research on Awiqli. See real-world data from Canadian patients on once-weekly insulin for diabetes care.
5,700 dQ&A community members share where they were diagnosed, first symptoms, and emotions—highlighting key differences between type 1 and type 2 journeys.
Our research with the ADA shows that people with diabetes are much worse off under the COVID-19 pandemic, compared to the nation as a whole.
We asked patients about using—and endocrinologists about prescribing—a connected insulin pen.
Concerns about family or friends getting COVID-19 and about getting COVID-19 oneself increased, as case numbers rose nationally over the summer.
Our research with the ADA reveals severe economic impacts of COVID-19 on Americans with diabetes, including high unemployment and care rationing.
Our fourth COVID-19 survey of U.S. diabetes patients highlights persistent concerns, economic stress, and changing behaviors despite easing lockdowns.
dQ&A reveals how Walmart’s CareZone deal, low mail-order NPS scores, and a pandemic push toward home delivery are reshaping pharmacy apps for diabetes.
Our third COVID-19 survey of U.S. diabetes patients found high infection concern, income loss, care changes, and challenges accessing healthy food and supplies.
